Your browser doesn't support javascript.
Myocarditis Associated With COVID-19.
Oleszak, Filip; Maryniak, Andrii; Botti, Evan; Abrahim, Christian; Salifu, Moro O; Youssef, Mary; Henglein, Victoria L; McFarlane, Samy I.
  • Oleszak F; Department of Internal Medicine, State University of New York (SUNY): Downstate Health Science University, Brooklyn, New York, USA.
  • Maryniak A; Department of Internal Medicine, State University of New York (SUNY): Downstate Health Science University, Brooklyn, New York, USA.
  • Botti E; Department of Internal Medicine, State University of New York (SUNY): Downstate Health Science University, Brooklyn, New York, USA.
  • Abrahim C; Division of Cardiology, Department of Internal Medicine, UMMS-Baystate Medical Center, Springfield Massachusetts, USA.
  • Salifu MO; Department of Internal Medicine, State University of New York (SUNY): Downstate Health Science University, Brooklyn, New York, USA.
  • Youssef M; Department of Internal Medicine, State University of New York (SUNY): Downstate Health Science University, Brooklyn, New York, USA.
  • Henglein VL; Department of Internal Medicine, State University of New York (SUNY): Downstate Health Science University, Brooklyn, New York, USA.
  • McFarlane SI; Department of Internal Medicine, State University of New York (SUNY): Downstate Health Science University, Brooklyn, New York, USA.
Am J Med Case Rep ; 8(12): 498-502, 2020.
Article in English | MEDLINE | ID: covidwho-890717
ABSTRACT
Coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic, with affecting to-date over 23 million people and causing over 800,000 deaths around the globe. The major pathogenetic mechanisms include inflammation, vasoconstriction and thrombogenesis. Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) typically manifests as fever, cough, shortness of breath, and exhibits radiographic evidence of bilateral pneumonic infiltrates. Recent meta-analyses have shown that myocardial injury, including viral myocarditis, is prevalent among infected patients, especially in patients requiring ICU level care. Diagnosis of viral myocarditis is multifactorial and involves detection of elevated cardiac biomarkers and echocardiographic evidence of cardiomyopathy, in the absence of diseased coronary arteries. Endomyocardial biopsy with histopathologic examination provides definitive confirmation. We present a case of a previously healthy 52-year-old male who presented clinically with suspected myocarditis with new-onset dilated cardiomyopathy (DCM) and systolic dysfunction as a sequela of infection with SARS-CoV-2. In this report we highlight the clinical presentation of echocardiographic findings and proposed pathogenetic mechanisms of myocarditis associated with COVID-19 which has a varied presentation, ranging from clinically silent to life-threatening arrhythmias with hemodynamic compromise.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews Topics: Long Covid Language: English Journal: Am J Med Case Rep Year: 2020 Document Type: Article Affiliation country: Ajmcr-8-12-19

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews Topics: Long Covid Language: English Journal: Am J Med Case Rep Year: 2020 Document Type: Article Affiliation country: Ajmcr-8-12-19